Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Current assets:
Cash and cash equivalents	$ 55,863	$ 43,822
Accounts receivable, net	33,422	13,627
Inventory, net	10,766	5,406
Prepaid expenses and other current assets	4,874	3,188
Total current assets	104,925	66,043
Property and equipment, net	3,713	3,072
Goodwill	2,715	2,715
License and distribution rights, net	62,044	36,000
Other intangible assets, net	211	703
Total assets	173,608	108,533
Current liabilities:
Accounts payable and accrued liabilities	46,545	21,539
Total current liabilities	46,545	21,539
Notes payable, net	58,515	51,652
Other long-term liabilities	654	5,600
Total liabilities	105,714	78,791
Commitments and contingencies (Note 11)
Stockholders' equity:
Preferred Stock, 5,000,000 shares authorized; Series A Non-Voting Convertible Preferred Stock. $.001 par value, 2,093,155 shares outstanding at both September 30, 2019 and December 31, 2018, respectively; Series B Non-Voting Convertible Preferred Stock, $.001 par value, 1,698 and 3,100 shares outstanding at September 30, 2019 and December 31, 2018, respectively.	2	2
Common Stock, $.001 par value; 175,000,000 shares authorized at September 30, 2019 and 125,000,000 shares authorized at December 31, 2018, respectively; 89,796,774 and 70,793,725 shares issued;89,781,283 and 70,778,234 shares outstanding at September 30, 2019 and December 31, 2018, respectively.	90	71
Additional paid-in capital	433,746	381,004
Treasury stock, at cost, 15,491 shares	(47)	(47)
Accumulated deficit	(365,897)	(351,288)
Total stockholders' equity	67,894	29,742
Total liabilities and stockholders' equity	$ 173,608	$ 108,533